Company intelligence / Profile preview

Tempus AI

Chicago, Illinois, United Statestempus.com ↗

Ownership: Public · TEM
Employees: ~2400
Development stage: Other

Overview

Tempus AI’s genomic and data-driven diagnostics are commercially available and have been adopted at scale across US medical centers; key clinical results include improved precision in cancer diagnosis/treatment, accelerated trial enrollment, and data-driven insights for therapy optimization. The company has supported ~1,500 research projects in 10 years, with large-scale publication and validation of its platform

Therapeutic areas: PsychiatryInfectious DiseasesCardiovascularOtherOncology
Modalities: Genomic sequencingDiagnostic testing (broad, including multiomics, not strictly drug/biologic modality)Data-enabled clinical decision supportClinical trial matching platform
Industry: Molecular Diagnostics

Partnerships

AstraZeneca (multi-year data licensing, research collaboration)GSK (GlaxoSmithKline, multi-year data licensing)Over 200 biopharma companies (various data and trial collaborations)SB Tempus (SoftBank joint venture in Japan)

Financials

Market cap: $12.5B
Total revenue: $1.3B
Enterprise value: $13.3B

Beyond the preview

Go deeper on Tempus AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tempus AI.